COMPANY PROFILE · UPDATED 18 NOV 2025

Aligos Therapeutics

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of…

South San Francisco, CA

aligos.com ↗

Healthcare & Biotech Biotech & Drug Discovery Medical Organizations Health Care Companies Sofware Companies In San Francisco Medical Organizations In San Francisco Public Companies In Peninsula Bay Area Biotechnology Companies

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2018
Headcount: 71
Open roles: 0
Last raised: Post Ipo Equity

LOCATIONS

Where they work

Aligos Therapeutics offices

Loading map…

South San Francisco, CAOne Corporate Dr. 2nd Floor

FUNDING

Capital raised

Total raised

$505,600,000

Investors

Armistice Capital Boxer Capital Cormorant Asset Management Deep Track Capital EcoR1 Capital Janus Capital Lawrence M. Blatt Logos Capital Novo Holdings Pivotal bioVenture Partners Roche Venture Fund Versant Ventures Vivo Capital Wellington Management

Funding rounds

Post Ipo Equity
$105MFeb 11, 2025
Post Ipo Equity
Roche Venture Fund, Lawrence M. Blatt, Armistice Capital, EcoR1 Capital, Deep Track Capital
$92MOct 22, 2023
Post Ipo Equity
$83.6MJun 30, 2021
Series B
Wellington Management, Cormorant Asset Management, Boxer Capital, Janus Capital, Pivotal bioVenture Partners, Logos Capital, Versant Ventures, Roche Venture Fund, Novo Holdings, Vivo Capital
$125MJan 9, 2020
IPO
UndisclosedJan 1, 2020
Series A
Versant Ventures, Novo Holdings, Roche Venture Fund, Vivo Capital
$100MDec 31, 2017

Funding data via Diffbot, SEC EDGAR filings and company announcements — a round from a filing or announcement links to it

OPEN ROLES

Roles at Aligos Therapeutics

Employbl doesn’t track Aligos Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

LEADERSHIP